Report
Log in or create a free account to download
Full Report
This report is one in a series on legal issues of interest to non-profit organizations engaged in or thinking about Venture Philanthropy work. It discusses the beginnings of Venture Philanthropy in drug development, the importance of an Interruption License, and how an Interruption License can help everyone involved, but most importantly, the patients who may benefit from a resulting product.
Log in or create a free account to download
Full Report
Related Content
-
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save lives by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships...Read Article -
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce the individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding...Read Article -
Silver to Gold: The Business of Aging
Opportunities presented by an aging population will not be fully realized unless business leaders act now to prepare for this irreversible shift in demography. To discuss the significance of population aging for the business sector and...Read Report -
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes to mind. However, technology and devices are proving to be valuable options for treating intractable illnesses. Technological solutions in the...Read Report11
-
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
11Katie O'Connor and Hadly Clark -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13 – 15, will convene regional and global leaders to discuss a wide range of issues and challenges shaping the Asia Pacific region including...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Towards Successful Aging in Asia
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...Read Report -
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report11
-
Catalyzing Action for Pharmacist-Provided Food Is Medicine Care
"Catalyzing Action for Pharmacist-Provided Food Is Medicine Care" provides background, insights, and actionable recommendations for pharmacies and key partners, including health-care payers and policymakers, to scale FIM interventions in...Read Report -
Improving Early Detection of Cognitive Impairment and Dementia
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...Read Report11 11
Diane Ty, Soo Borson, MD, and Katie Partrick, PhD